19 Nov 2018 | 8:13 PM
 

Natco Pharma Ltd. Share Price Live (BSE)
0

BSE Code: 524816 | NSE Symbol: NATCOPHARM
744.00
8.95
(1.22 %)
19 Nov 2018 | 03:41 PM
Change company
  • Open (Rs)
    735.00
  • Prev. close (Rs.)
    735.05
  • High (Rs.)
    750.00
  • Low (Rs.)
    735.00
  • 52W H (Rs.)
    1,061.95
  • 52W L (Rs.)
    637.40
  • Volume
    12369
  • MCap (Rs in Cr.)
    13,736.77
0
0.00
(0.00 %)
  • Open (Rs)
    0.00
  • High (Rs)
    0.00
  • Low (Rs)
    0.00
  • Prev. close(Rs)
    0.00
  • Contracts Tra.
  • Turnover (Cr.)
    N.A.
  • Open Interest
  • Open Int. chg
    0.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
37.74
Operating Margin (%)
42.49
Gross Profit Margin (%)
39.46
Net Profit Margin (%)
31.86
Total Debt/Equity
0.06
Dividend payout Ratio (Net Profit)
26.09
Earning Retention Ratio
73.87

News

05 Nov 2018 - 16:43:00-Natco Pharma Monday reported over two-fold increase in consolidated profit after tax at Rs 181...
09 Aug 2018 - 10:43:00-Drug firm Natco Pharma today reported a 93...
02 Jul 2018 - 13:50:00-Natco Pharma today said it has launched fixed dose combination of Sofosbuvir-Daclatasvir tablets for...
11 Jun 2018 - 00:01:00-Natco Pharma Limited has said that it has launched a generic version of Posaconazole Inject...

Announcements

09-Nov-2018
Natco Pharma - Buyback
09-Nov-2018
Natco Pharma - Public Announcement - Buyback of Shares
09-Nov-2018
Natco Pharma - Corporate Action-Intimation of Buy back
08-Nov-2018
Natco Pharma - Announcement under Regulation 30 (LODR)-Investor Presentation
08-Nov-2018
Natco Pharma - Investor Presentation

Religare Research

19 Nov 2018 | 03:31 PM
Symphony Ltd reported mix set of numbers for Q2FY19. While revenue growth was in-line with our proje...
19 Nov 2018 | 11:32 AM
Highlights : • Moderate weakness was shown for most Agri counters as profit booking set in for the ...
19 Nov 2018 | 10:35 AM
DTF
19 Nov 2018 | 10:14 AM
The rupee settled at 71.92 to a dollar, its highest since Sep. 14, against 71.98 at previous close. ...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
4,00,000 90.05 29.37 0.48
4,00,000 90.05 141.87 0.47
4,00,000 90.05 150.22 0.47
4,00,000 90.05 50.44 0.48
1,60,000 35.89 76.86 0.35

Shareholding Pattern

       
Promotors48.34%
Mutual Funds/UTI5.13%
FI/Banks0.97%
Insurance0.97%
FII24.32%
Government0.00%
Others4.05%

Peer Group

Company Intraday Graph
 Abbott India Ltd.
7,589.15(-0.21)
3280
 Sanofi India Ltd.
6,047.35(-0.36)
3325
 Pfizer Ltd.
2,845.00(0.57)
3370
 Dr. Reddy`s Laboratories Ltd.
2,527.15(2.28)
3294

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Natco Pharma Ltd.3.45-8.15-44.85
NIFTY(S&P CNX)178.65-621.6522.30
BSE SENSEX612.40-1,888.68387.00
BSE 500234.43-1,014.69-455.35

Corporate Details

Key Personal
A K S Bhujanga Rao
Director & President (R&D and Tech.)
A K S Bhujanga Rao
President & Director
D Linga Rao
Director & President (Tech. Affairs)
Key Address
Registered Office
NATCO House Road # 2 Banjara Hills,Hyderabad,Telangana

Tel:040-23547532, Fax:040-23548243

investors@natcopharma.co.in
http://www.natcopharma.co.in
Registrar Office
Venture Capital & Corporate Investments Pvt. Ltd.
Add. :No. 12-10-167 Bharat Nagar